Clinical Trial

Emulation of the EMPEROR-Preserved Trial Using Healthcare Claims Data

Completed
View on ClinicalTrials.gov →
Summary
Investigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Protocol Amendment History 2 changes
critical Trial completed 2026-07-10
critical Primary endpoint(s) modified 2026-06-12
Trial Details
NCT Number NCT07599293
Lead Sponsor Brigham and Women's Hospital
Collaborators: Food and Drug Administration (FDA)
Conditions Heart Failure With Preserved Ejection Fraction, Chronic Heart Failure, Type 2 Diabetes Mellitus
Enrollment 39,614 participants
Start Date 2024-10-13
Primary Completion 2026-06-19 (estimated)
Study Completion 2026-06-19 (estimated)
Updated on ClinicalTrials.gov 2026-07-09